Regeneron Pharmaceuticals, Inc (REGN) insider trading
Every open-market stock purchase and sale by Regeneron Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Healthcare.
Insider activity at a glance
- Andrew J Murphy (C-suite exec) and 3 others sold $6.5M in the last 90 days.
- Last insider buy: Sanofi (Insider), $13.7M, 9 years ago.
- Congress: Gilbert Cisneros sold $1K to $15K, 5 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $16.1M (16 sales). Last close $805.67 on Oct 21, 2026.
Recent REGN insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $361K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $354K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $296K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $292K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $218K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $214K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $207K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $173K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $167K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $163K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $147K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $97.7K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $93.7K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $80.7K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $56.3K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $51.2K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $41.9K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $39.1K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $29.6K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $26.5K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $20.6K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $19.1K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $18.2K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $12.1K |
| Oct 14, 2026 | Andrew J Murphy (C-suite exec) | Sold | $10.6K |
Who's trading REGN
- Andrew J Murphy, VP: sold $3.2M (27 sales), last Oct 14, 2026
- Marion McCourt, VP: sold $2M (2 sales), last Sep 3, 2026
- Kathryn Guarini, Director: sold $660K (2 sales), last Sep 2, 2026
- Joseph J Larosa, VP: other filings, last Aug 19, 2026
- Christopher R. Fenimore, CFO: other filings, last Aug 18, 2026
- Huda Y Zoghbi, Director: sold $1.9M (12 sales), last Aug 10, 2026
- Arthur F Ryan, Director: sold $379K (33 sales), last Jul 2, 2026
- Gilbert Cisneros, Representative: bought $8K (1 buy), sold $8K (1 sale), last May 15, 2026
- Alan Armstrong, Senator: bought $8K (1 buy), last Mar 27, 2026
- Julia Letlow, Representative: bought $8K (1 buy), last Feb 12, 2026
- Jason Pitofsky, VP: sold $1.9M (12 sales), last Feb 9, 2026
- Bonnie L Bassler, Director: sold $1.8M (2 sales), last Jan 7, 2026
- Michael S Brown, Director: other filings, last Jan 2, 2026
- N Anthony Coles, Director: other filings, last Jan 2, 2026
- Joseph L Goldstein, Director: other filings, last Jan 2, 2026
Get free alerts when an insider at Regeneron Pharmaceuticals, Inc files a new trade →